New lupus drug enters first human safety trials
NCT ID NCT05835986
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 24 times
Summary
This study tests a new drug called RO7507062 in 70 people with systemic lupus erythematosus (SLE). The main goal is to check its safety and find the right dose. The study has two parts: one where participants get a single dose, and another where the dose is split over time. This is an early-stage trial, so it focuses on safety rather than effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CREA Hospital Mexico Americano
Guadalajara, Jalisco, 44620, Mexico
-
Centre For Human Drug Research
Leiden, 2333, Netherlands
-
Chang Gung Medical Foundation - Linkou
Taoyuan, 333, Taiwan
-
Charité Research Organisation GmbH
Berlin, 10117, Germany
-
Chung Shan Medical University Hospital
Taichung, 40201, Taiwan
-
Clinica De La Costa
Barranquilla, 080020, Colombia
-
Clínica San Juan Bautista CSJB
Lima, 15431, Peru
-
FARMOVS (Pty) Ltd
Bloemfontein, 9301, South Africa
-
Groupe Hospitalier Pitie-Salpetriere
Paris, 75651, France
-
Hospital Angeles De Lindavista
Mexico City, Mexico CITY (federal District), 07760, Mexico
-
Hospital General De Mexico
Mexico City, Mexico CITY (federal District), 6726, Mexico
-
Hospital General Universitario Gregorio Marañon
Madrid, 28007, Spain
-
Hospital Pablo Tobon Uribe
Medellín, 050034, Colombia
-
Hospital Umum Sarawak
Kuching, 93586, Malaysia
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Reina Sofia
Córdoba, 14004, Spain
-
Hôpital Saint Eloi
Montpellier, 34295, France
-
Oncomedica S.A.
Montería, 230002, Colombia
-
Ramathibodi Hospital, Mahidol Uni
Bangkok, 10400, Thailand
-
UCL Hospital NHS Trust
London, NW1 2PG, United Kingdom
-
Universitätsklinikum Duesseldorf
Düsseldorf, 40225, Germany
-
Uniwersytecki Szpital Kliniczny w Poznaniu
Późna, 61-848, Poland
-
Wojskowy Instytut Medyczny- Panstwowy Instytut Badawczy
Warsaw, 04-141, Poland
Conditions
Explore the condition pages connected to this study.